Theravance Biopharma TBPH Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherPrepaidExpenseCurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's prepaid & other current?
- Theravance Biopharma (TBPH) reported prepaid & other current of $7.38M in Q1 2026.
- How has Theravance Biopharma's prepaid & other current changed year-over-year?
- Theravance Biopharma's prepaid & other current increased by 82.1% year-over-year, from $4.06M to $7.38M.
- What is the long-term trend for Theravance Biopharma's prepaid & other current?
- Over 5 years (2020 to 2025), Theravance Biopharma's prepaid & other current has grown at a -6.1% compound annual growth rate (CAGR), from $10.36M to $7.56M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.